Texas Instruments (TXN), the king of analog semiconductors, has been a steady performer for retail investors navigating the wild semiconductor cycles. With a recent close putting the stock near its yearly highs, TXN shows resilience amid broader chip industry headwinds like the 2023-2024 inventory glut that hammered many peers. But digging into the fundamentals reveals a company rebounding from a post-pandemic slowdown, with revenue dipping but profitability metrics hinting at a turnaround fueled by analyst forecasts for growth ahead. Insider selling has picked up lately, though, which warrants a closer look as we unpack the numbers.
Revenue Growth: A Rollercoaster Ride Tied to Chip Demand
TXN’s revenue tells a classic semi story—boom times during COVID-driven electronics demand, followed by a sharp correction. From $13.4 billion in 2016, sales climbed steadily to a peak of $20.0 billion in 2022, a robust 50% increase over six years, driven by everything from automotive chips to industrial applications. Revenue per employee mirrored this, hitting $607K in 2022 from $448K in 2016 (35% rise), underscoring efficient scaling as headcount grew modestly from 30K to 34K employees.
Then came the bust: 2023 saw revenue plunge 13% to $17.5 billion, and 2024 another 11% drop to $15.6 billion. This correlates directly with the global chip inventory overhang, exacerbated by softening demand in consumer electronics and autos post-COVID. Gross margins, a key gauge of pricing power in semis (since analog chips are hard to commoditize), peaked at 68.8% in 2022 but eroded to 58.1% in 2024—a 15% relative decline—reflecting aggressive discounting to clear stockpiles.
Stock price action tracked this closely. Yearly lows climbed from $47 in 2016 to $155 in 2024 (231% total gain), while highs soared from $75 to $220 (193% rise). The stock hit pandemic-era euphoria around 2021-2022 highs near $200, then pulled back with revenue, but has since recovered to recent levels above 2024 highs, signaling investor faith in TXN’s moat.
Profitability and Earnings: High Margins Under Pressure, But ROE Still Impressive
Earnings paint a resilient picture despite the revenue dip. Net income rocketed from $3.6 billion in 2016 to $8.7 billion in 2022 (143% growth), with EPS surging from $3.48 to $9.55 (175% jump). EBT margins hit an eye-popping 50.1% in 2022, far above peers, thanks to TXN’s asset-light model and 90%+ gross margins on proprietary analog tech—crucial for fending off competition from fabless giants like Nvidia.
Post-2022, net income fell 45% to $4.8 billion in 2024, with EPS at $5.26 (down 45% from peak). ROE, a vital measure of shareholder value creation, dropped from 68.7% in 2021 to 28.3% in 2024, still healthy but signaling efficiency strains. ROIC followed suit, from 49.4% to 14.9%, highlighting how capex spikes hurt returns on invested capital.
Major events amplified these swings: The 2018-2019 U.S.-China trade war disrupted supply chains, yet TXN grew revenue 6% amid it, thanks to diversified fabs. COVID supercharged demand in 2020-2022, but 2023’s “chip recession” (echoing 2019’s mini-downturn) led to TXN’s first revenue decline in years. In response, management ramped U.S. manufacturing investments, announcing $30 billion over years for domestic fabs—a hedge against geopolitical risks.
Cash Flow and Balance Sheet: Capex Surge Squeezes Free Cash, Debt Climbs
Cash generation remains a strength, but free cash flow (FCF) per share cratered from $6.47 in 2022 to $1.86 in 2024 (71% drop), as capex ballooned from $2.8 billion to $4.6 billion (66% increase). Capex/share hit -$5.07, reflecting heavy factory builds—smart for long-term supply security but painful short-term, since FCF funds dividends (TXN’s prized 3%+ yield) and buybacks.
Operating cash flow held up at $6.3 billion in 2024 (down 28% from 2022 peak), but total debt swelled to $14.0 billion (64% rise since 2020), pushing net debt to $9.2 billion. Book value per share stabilized around $18-$19, supporting a PB ratio hovering at 10x historically, now nearer 10. This debt load isn’t alarming for a cash cow like TXN (net debt/EBITDA still manageable), but it correlates with EV/FCF spiking over 100x recently—pricey if FCF doesn’t rebound.
Working capital ballooned to $11.4 billion in 2024 (up 26% from 2020), a buffer against cycles. Shares outstanding shrank slightly to 912 million, boosting per-share metrics.
Valuation: Trading at a Premium, But Justified?
Valuation multiples expanded with growth: PE from 22x in 2016 to 36x in 2024 (EPS trough), PS from 5.5x to 10.9x, reflecting TXN’s premium for stability. Compared to 2022’s cheaper 17x PE, today’s levels suggest the market anticipates recovery. EV/Sales at 11.3x in 2024 (vs. 5.6x in 2016) prices in dominance in analog (60% market share), where barriers are high.
Stock price evolution vs. fundamentals? From 2016-2022, shares crushed revenue growth (up ~300% implicitly from low/high data vs. 50% revenue rise), rewarding quality. The 2023-2024 dip saw stock hold better than earnings (-30% vs. -45% EPS drop), classic for dividend aristocrats.
Insider Activity: All Sells, No Buys—A Caution Flag?
Insider transactions over the past year show zero buys across all months, with sells totaling over $27 million in value. Activity ramped in late 2025 and early 2026: a SVP sold 1,500 shares in Aug 2025, directors/SVPs unloaded 10K+ in Nov, and Feb 2026 saw a flurry—six transactions including the CFO dumping 71K shares worth $15.9 million, plus SVPs moving 20K+ shares. These are routine (often 10b5-1 plans), but the one-sided flow amid no buys could signal insiders see limited near-term upside, especially post-recovery rally. Watch for patterns; historically, TXN insiders sell into strength.
Analyst Forecasts: Revenue Rebound and EPS Growth Ahead
Analysts peer optimistically: Revenue projected to climb from $15.6 billion in 2024 to $17.7 billion in 2025 (13% growth), accelerating to $19.6 billion in 2026 (11% YoY) and $24.1 billion by 2028 (23% from 2025). Net income follows, from $4.8 billion to $5.0 billion (2025), then $8.1 billion by 2028 (62% cumulative), with EPS hitting $8.99 (71% from 2024).
This assumes semi cycle upturn—AI edge computing, EVs, and industrials boosting analog demand—plus TXN’s 300mm wafer transition cutting costs (depreciation up to $2.0 billion in 2025). Margins may stabilize at 57%, but ROA/ROE around 14-30% still beat industry averages. Capex eases to $3.2 billion in 2026, freeing FCF for shareholders.
Price Outlook: Modest Expectations Around Current Levels
Relative to the recent close, analyst targets imply a high-end upside of about 19%, a mean that’s roughly flat (-1%), and a low signaling -29% downside risk. This tight range reflects confidence in recovery but caution on macro (e.g., potential recession hitting autos). Paired with forecasts, forward PE drops to 25x by 2028—reasonable for TXN’s 20%+ long-term EPS growth potential.
Wrapping It Up: Buy the Dip or Wait?
TXN’s story is one of cyclical strength with a fortress balance sheet—$11B+ working capital, consistent cash flow, and a dividend streak spanning decades. The stock’s outperformance vs. fundamentals during upcycles (e.g., ROE >60% fueling 4x gains from 2016 lows) makes it a retail favorite, but recent insider sells and debt growth temper enthusiasm. If semis revive as predicted (think AI wearables, not just GPUs), TXN could revisit $220+ highs easily. For everyday investors, it’s a hold with 10-20% upside if execution shines; dollar-cost average on dips below recent lows. Just keep an eye on China exposure and capex returns—those will dictate the next leg. (Word count: 1,128)